# Ligand Pharmaceuticals INC. 401(k) Plan
Source: https://planprovider.pro/companies/ligand-pharmaceuticals-inc-401k-plan

> Ligand Pharmaceuticals INC.'s 401(k) plan: 69 participants, plan year 2024 financials, providers, and benchmarks from Form 5500.

Form 5500 filing data for plan year 2024.

## Plan Snapshot

- **Plan Sponsor:** Ligand Pharmaceuticals INC.

- **Sponsor EIN:** 770160744

- **Sponsor Address:** 3911 SORRENTO VALLEY BLVD, SAN DIEGO, CA, 92121

- **Plan Type:** 401(k)

- **Total Participants:** 69

- **Total Assets:** $28.9M

## Key Plan Design Features

- **Auto-Enrollment:** Yes

- **Auto-Escalation:** No

- **Allows Roth Contributions:** No

- **Participant Loans:** No

- **Participant-Directed Investments:** Yes

- **ERISA Section 404(c) Fiduciary Safe Harbor:** Yes

## Plan Financials by Year

| Year|Participants|Total Assets|Employer Contrib.|Employee Contrib.|

| 2024|69|$28.9M|$351,122|$1.2M|

| 2023|60|$27.8M|$380,611|$1.2M|

| 2022|76|$26.0M|$780,447|$2.4M|

## Service Providers (Schedule C)

Vendors paid $5,000 or more for services to the plan, ranked by total compensation (direct + indirect fees).

| Provider Name|
Role|
Direct Compensation|
Indirect Compensation|
Total Fees|

| JGD & ASSOCIATES LLP|Auditor|$9,750|—|$9,750|

### Verified Provider Profiles

Direct links to verified profiles of matched retirement plan providers on PlanProvider.Pro:

- [JGD & ASSOCIATES LLP](https://planprovider.pro/provider/jgd-and-associates-llp) — Auditor

## Plan Fees & Expenses

Annual service provider fees and administrative expenses sourced from DOL Form 5500 filings.

- **Total Service Provider Fees:** $9,750

- **Estimated Expense Ratio:** 0.034% of plan assets

### Historical Administrative Expenses

Breakdown of administrative expense categories reported on Form 5500 filings.

| Year|
Total Admin Expenses|
Investment Mgmt Fees|
Contract Admin Fees|
IQPA Audit Fees|
Professional Fees|

| 2024|$1,675|$10,296|—|$9,750|—|

| 2023|-$12,059|$7,972|—|—|—|

| 2022|-$4,341|$9,986|—|—|—|

## Similar Plans

- [Jasper Therapeutics, INC.](https://planprovider.pro/companies/jasper-therapeutics-inc-401k-plan) — 69 participants

- [Sansum Diabetes Research Institute](https://planprovider.pro/companies/sansum-diabetes-research-institute-401k-plan) — 70 participants

- [Kateeva, INC](https://planprovider.pro/companies/kateeva-inc-401k-plan) — 70 participants

- [Applied Invention, LLC](https://planprovider.pro/companies/applied-invention-llc-401k-plan) — 72 participants

- [Assembly Biosciences, INC.](https://planprovider.pro/companies/assembly-biosciences-inc-401k-plan) — 72 participants

- [Octave Bioscience, INC.](https://planprovider.pro/companies/octave-bioscience-inc-plan) — 66 participants

[View full interactive plan profile on PlanProvider.Pro](https://planprovider.pro/companies/ligand-pharmaceuticals-inc-401k-plan)

© 2026 PlanProvider.Pro